# Semaglutide FAQ: Straight Answers from the Research

> Semaglutide questions answered from the published record: MASH and the liver, weight loss, how it works, dosage studied, side effects, half-life, oral vs injection, and the tirzepatide comparison.

Direct answers drawn from the trials, each tied to a source. No advice, no dosing for individuals.

## Can semaglutide help fatty liver disease (MASH)?

Yes, by the trial evidence. In the ESSENCE phase-3 trial of biopsy-confirmed MASH with stage 2-3 fibrosis, once-weekly semaglutide 2.4 mg resolved steatohepatitis without worsening fibrosis in 62.9% of participants versus 34.3% on placebo, and improved fibrosis in 36.8% versus 22.4% [8]. The benefit was confirmed on liver biopsy. This anchored the 2025 MASH indication.

## Will semaglutide reduce belly fat?

The trials measured total body weight, not belly fat specifically. In STEP 1, once-weekly subcutaneous semaglutide 2.4 mg produced a mean body-weight change of -14.9% versus -2.4% with placebo over 68 weeks in adults with overweight or obesity without diabetes [1]. Exploratory analyses also reported reduced waist circumference and improved cardiometabolic risk markers [3].

## What is semaglutide?

Semaglutide is a peptide medicine — a 31-amino-acid copy of the gut hormone GLP-1, engineered to last about a week so it can be dosed once weekly by injection or once daily as a tablet [9]. It is approved for type 2 diabetes, chronic weight management, cardiovascular risk reduction, and MASH [23]. In STEP 1, mean body weight fell 14.9% versus 2.4% with placebo [1].

## What is semaglutide used for?

Semaglutide is approved for type 2 diabetes, chronic weight management, reduction of major adverse cardiovascular events in adults with established cardiovascular disease and overweight or obesity, and, since 2025, metabolic dysfunction-associated steatohepatitis (MASH) [23]. In its pivotal weight trial, STEP 1, it produced a mean 14.9% body-weight reduction versus 2.4% with placebo [1].

## How does semaglutide work?

It mimics the gut hormone GLP-1: it boosts glucose-dependent insulin, suppresses glucagon, and slows gastric emptying, while reaching brain appetite circuits to reduce hunger [4]. In rodents it accessed the brainstem, area postrema, hypothalamic arcuate nucleus, and parabrachial nucleus, cutting food intake and shifting food preference without lowering energy expenditure [4].

## How does semaglutide work for weight loss?

Mostly through the brain. Semaglutide reaches appetite-regulating circuits — activating satiety (POMC/CART) neurons and inhibiting hunger (NPY/AgRP) neurons — so people eat less rather than burn more [4]. That mechanism produced a mean 14.9% body-weight reduction in STEP 1 versus 2.4% with placebo over 68 weeks [1].

## What is the semaglutide dosage for weight loss?

In the STEP trials the documented subcutaneous schedule titrated upward — 0.25 mg weekly, then 0.5, 1.0, 1.7, reaching 2.4 mg once-weekly maintenance [1]. That regimen produced a mean 14.9% body-weight change versus 2.4% with placebo [1]. This is the dose studied, reported in the third person; it is not a recommendation for any individual.

## How many mg is 40 units of semaglutide?

This site does not convert insulin-syringe "units" to milligrams, because that calculation depends entirely on a specific product's concentration and is exactly where compounded-product dosing errors have occurred. Semaglutide is dosed in milligrams per its labeling; a pharmaceutical-sciences review summarizes its structure-based long half-life and once-weekly or once-daily dosing [9]. Unit conversions are a question for a prescriber, not a reading room.

## What is compounded semaglutide?

Compounded semaglutide is semaglutide prepared by a compounding pharmacy rather than the approved manufactured product. It was permitted during a federally declared shortage and curtailed once that shortage was declared resolved in 2025 [23]. The approved-product trial evidence — including the cardiovascular benefit seen in SUSTAIN-6 (HR 0.74) [2] — was generated with the manufactured product, not compounded preparations.

## What are the side effects of semaglutide?

The dominant side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation — mostly mild-to-moderate and transient, concentrated during dose escalation [14]. A safety review reported nausea in roughly one-third of patients and noted increased biliary disease, with thyroid and pancreatic signals unconfirmed [5]; SUSTAIN-6 flagged more retinopathy complications with rapid glucose correction [2].

## How long does it take for semaglutide to work?

Effects build gradually as the dose is titrated over weeks; the pivotal weight result was measured at 68 weeks (-14.9% vs -2.4% with placebo) [1]. Appetite changes are often described early, but the schedule climbs slowly for tolerability, and the large weight figures reflect roughly a year of treatment [1]. Timelines vary by person and indication.

## How long does semaglutide stay in your system?

Semaglutide's elimination half-life is approximately one week (commonly cited as ~165-168 hours), with effectively complete clearance roughly five weeks after the last dose [9][23]. That long persistence comes from reversible albumin binding via its fatty-acid side chain plus DPP-4 resistance [9], and it underlies both once-weekly dosing and multi-week washout guidance.

## What is the half-life of semaglutide?

Approximately one week — commonly cited as about 165-168 hours — for both the subcutaneous injection and the oral tablet [9]. A pharmaceutical-sciences review attributes this structure-based long half-life to the albumin-binding fatty di-acid side chain and DPP-4 resistance [9], which is why the drug clears roughly five weeks after the final dose [23].

## Is oral semaglutide as effective as the injection?

A meta-analysis of once-daily oral semaglutide reported efficacy in glycemic control and weight, with cardiovascular outcomes consistent with the GLP-1 receptor agonist class in type 2 diabetes [11]. The oral tablet's challenge is absorption: bioavailability is only about 0.4-1%, which is why strict fasted dosing matters [24]. Higher oral doses were studied to push efficacy further [11].

## How long does it take for semaglutide to suppress appetite?

The trials did not clock appetite to a precise hour, but the mechanism is central and the effect is typically described early in treatment. In rodents, semaglutide reached brainstem and hypothalamic appetite circuits and reduced food intake [4]. People commonly report a quieter relationship with food within the first weeks, though this is anecdotal and varies by person.

## Why am I not losing weight on semaglutide?

Response varies, and this site cannot advise on any individual case. In STEP 1 the mean change was -14.9%, but that is an average across many people, with a range around it [1]. Weight also tends to plateau as the dose stabilizes, and the drug works by reducing intake, so results track with that mechanism [4]. Specific concerns belong with a prescriber, not a reading room.

## Does semaglutide make you tired?

Fatigue is commonly reported by users, especially in the first day or two after a dose and during early weeks, though it is not the dominant trial-level adverse effect. The trial record is led by gastrointestinal events [5], with cardiovascular benefit seen in SUSTAIN-6 (HR 0.74) [2]. Reported tiredness is anecdotal, often linked to eating and drinking too little, and usually eases with time.

## Is semaglutide a GLP-1?

Yes. Semaglutide is a GLP-1 receptor agonist — a long-acting analogue of the gut hormone glucagon-like peptide-1 that activates the GLP-1 receptor [9]. That class action is what produced the cardiovascular benefit in SUSTAIN-6 (HR 0.74; 95% CI 0.58-0.95) [2] and underlies its effects on blood sugar, appetite, and the other organs in its record.

## Does semaglutide cause hair loss?

Hair shedding appears as a pharmacovigilance signal for semaglutide and tirzepatide [21], but the pattern fits telogen effluvium — reversible, diffuse shedding triggered by rapid weight loss rather than the drug itself. A dermatology study linked telogen effluvium to the magnitude and rate of weight loss [22]. People who report it generally describe it as temporary, in line with that explanation.

## How fast does semaglutide work?

Deliberately slowly. The dose is titrated over weeks to limit gut side effects [14], and the headline weight result was measured at 68 weeks: -14.9% versus -2.4% with placebo [1]. Some effects, like a quieter appetite, are described early, but the large numbers in the record reflect about a year of treatment, not days [1].

## What is the difference between semaglutide and tirzepatide?

Tirzepatide activates two gut-hormone receptors (GIP and GLP-1); semaglutide activates one (GLP-1). In the SURMOUNT-5 head-to-head trial of adults with obesity, tirzepatide produced greater mean weight loss at 72 weeks (-20.2% vs -13.7%; P<0.001) [7]. Semaglutide, however, carries the broader outcomes record across heart, kidney, and liver [3][6][8].

## What is the downside of semaglutide?

Mainly three things. Gastrointestinal side effects dominate and lead discontinuations [5]; the weight tends to return after stopping (a mean regain of ~11.6 percentage points within a year in the STEP 1 extension) [19]; and some lean (muscle) mass is lost along with fat [18]. The cardiovascular benefit is real (SUSTAIN-6 HR 0.74) [2], but the record frames this as a chronic treatment.

---

A dark reading room for an approved medicine's record — study summaries traced to their sources, never a prescription.